Siemens Healthineers AG

Siemens Healthineers maintains a capital structure characterized by significant leverage, with long-term debt of €14.8 billion against total equity of €18.0 billion, resulting in a debt-to-equity ratio of 0.82. The company holds €2.18 billion in cash and equivalents, leading to a net cash position that is negative after subtracting total debt, which contributes to a medium liquidity risk assessment. The current ratio stands at 1.11, indicating adequate but tight short-term liquidity coverage. Operating cash flow of €3.53 billion supports the debt service obligations, while free cash flow is reported at €1.68 billion after capital expenditures of €818 million.

Profitability metrics show a return on equity of 11.62% and a return on assets of 4.72%. The company generated €23.38 billion in revenue, with a gross profit of €9.03 billion and operating income of €3.15 billion, culminating in net income of €2.14 billion. While specific cohort median comparisons are not provided in the input data, the gross margin of approximately 38.6% reflects the typical profile of a high-value medical technology provider with significant software and service components. The operating margin of 13.5% demonstrates efficient cost management relative to the scale of operations.

Revenue concentration details by segment or geography are not explicitly provided in the available data sections, preventing a detailed analysis of exposure risks. The classification indicates activity in Application Software, suggesting a diversified mix of hardware and software offerings, but specific revenue breakdowns are absent from the current snapshot. The company’s primary competitors in the broader technology space include Microsoft, Salesforce, and ServiceNow, although these are not direct peers in the medical device sector, highlighting a potential classification mismatch in the competitor context.

Growth trajectory analysis is limited by the absence of historical period data in the input, preventing a year-over-year or quarter-over-quarter trend assessment. The current financial snapshot provides a single-period view of revenue and net income, but without historical context, the direction and sustainability of growth cannot be quantified from the provided data. The company’s ability to maintain its current revenue base of €23.38 billion will depend on future market demand and competitive positioning, which are not detailed in the historical records provided.

Risk factors include medium liquidity risk and medium dilution risk, with key flags noting negative net cash and mentions of dilution or offering risk in source documents. The negative net cash position implies reliance on external financing or operating cash flow generation to meet obligations, which could be strained in adverse economic conditions. The dilution risk suggests potential equity issuances or option exercises that could impact per-share metrics, although the basic and diluted shares outstanding are currently identical at 1.12 billion.

Recent events and analyst sentiment indicate a mean price target of €46.22, with a median of €46.00, reflecting a consensus view of modest upside or stability. The mean recommendation of 2.04 suggests a buy rating, supported by 8 strong-buy and 8 buy ratings against 7 holds. No specific filing, news, or transcript observations are provided in the input data to detail recent corporate actions or strategic announcements.

Revenue grew 4.5% year-over-year to EUR 23.4 billion in fiscal 2025, demonstrating consistent top-line expansion.

Net income increased 10.4% to EUR 2.1 billion in fiscal 2025, outpacing revenue growth and indicating margin expansion.

Return on equity of 11.6% substantially outperforms the 3.66% median return observed across the software peer group.

Analysts project 393% upside to a mean price target of EUR 46.22, reflecting strong institutional confidence.

The company carries a high credit risk flag, signaling potential difficulties in meeting financial obligations or debt servicing.

Debt-to-equity ratio of 0.82 places the company in the bottom quartile compared to the software cohort median of 0.06.

Medium dilution risk exists, potentially eroding shareholder value through future equity issuance or convertible debt instruments.

Medium liquidity risk suggests potential challenges in converting assets to cash quickly to meet short-term liabilities.

Free cash flow growth of 8.9% in fiscal 2025 lagged behind the 10.4% growth rate of net income.

Revenue €5.68B, −3,9% YoY; Operating income −13,8% YoY.

• ▍Revenue €5.68B, −3,9% YoY
• ▍Operating income −13,8% YoY
• ▍Net income −4,5% YoY
• ▍Free cash flow −9,9% YoY
• ▍Net margin 8.9%

Revenue €5.40B, −1,5% YoY; Operating income −3,0% YoY.

• ▍Revenue €5.40B, −1,5% YoY
• ▍Operating income −3,0% YoY
• ▍Net income −5,3% YoY
• ▍Free cash flow −3,4% YoY
• ▍Net margin 8.3%

Revenue €6.32B, −0,1% YoY; Operating income −6,7% YoY.

• ▍Revenue €6.32B, −0,1% YoY
• ▍Operating income −6,7% YoY
• ▍Net income −4,5% YoY
• ▍Free cash flow −11,2% YoY
• ▍Net margin 9.3%

Revenue €5.66B, +4,4% YoY; Operating income +7,8% YoY.

• ▍Revenue €5.66B, +4,4% YoY
• ▍Operating income +7,8% YoY
• ▍Net income +17,7% YoY
• ▍Free cash flow +252,9% YoY
• ▍Net margin 9.7%

Revenue €5.91B; Operating income €841.0M.

• ▍Revenue €5.91B
• ▍Operating income €841.0M
• ▍Net margin 9.0%

Revenue €5.48B; Operating income €698.0M.

• ▍Revenue €5.48B
• ▍Operating income €698.0M
• ▍Net margin 8.7%

Revenue €6.33B; Operating income €945.0M.

• ▍Revenue €6.33B
• ▍Operating income €945.0M
• ▍Net margin 9.7%

Revenue €5.42B; Operating income €680.0M.

• ▍Revenue €5.42B
• ▍Operating income €680.0M
• ▍Net margin 8.6%

Revenue €23.38B, +4,5% YoY; Operating income +12,4% YoY.

• ▍Revenue €23.38B, +4,5% YoY
• ▍Operating income +12,4% YoY
• ▍Net income +10,4% YoY
• ▍Free cash flow +8,9% YoY
• ▍Net margin 9.2%

Revenue €22.36B, +3,1% YoY; Operating income +31,5% YoY.

• ▍Revenue €22.36B, +3,1% YoY
• ▍Operating income +31,5% YoY
• ▍Net income +28,7% YoY
• ▍Free cash flow +57,7% YoY
• ▍Net margin 8.7%

Revenue €21.68B, −0,2% YoY; Operating income −27,1% YoY.

• ▍Revenue €21.68B, −0,2% YoY
• ▍Operating income −27,1% YoY
• ▍Net income −25,9% YoY
• ▍Free cash flow −38,1% YoY
• ▍Net margin 7.0%

Revenue €21.71B, +20,6% YoY; Operating income +13,8% YoY.

• ▍Revenue €21.71B, +20,6% YoY
• ▍Operating income +13,8% YoY
• ▍Net income +17,9% YoY
• ▍Free cash flow +7,6% YoY
• ▍Net margin 9.4%